Please enable JavaScript to continue using this application.

Compare $EBS vs $SRZN | Chartloom

Compare

$EBS vs $SRZN

Emergent BioSolutions Inc · Surrozen Inc

EBS

Emergent BioSolutions Inc

SRZN

Surrozen Inc

Compare $EBS vs $SRZN

Comparing Emergent BioSolutions Inc and Surrozen Inc

EBSEmergent BioSolutions Inc

SRZNSurrozen Inc

EBSEmergent BioSolutions Inc

Market cap

$364M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-9.6%

YTD performance

-43.6%

52W performance

-28.6%

FCF yield

9.7%

SRZNSurrozen Inc

Market cap

$345M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

118.58x

Rev growth (TTM)

-8.8%

YTD performance

37.8%

52W performance

111.5%

FCF yield

-10.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EBS

SRZN

Detailed metrics comparison

EBS

Emergent BioSolutions Inc

SRZN

Surrozen Inc

Market Cap

EBS$364M

SRZN$345M

Enterprise Value

EBS$806M

SRZN$243M

Price

EBS$7.06

SRZN$29.69

P/E Ratio

EBSN/A

SRZNN/A

P/S Ratio

EBS0.47x

SRZN29.95x

EV/Sales

EBS1.05x

SRZN21.08x

EV/EBITDA

EBS3.65x

SRZN0.00x

P/B Ratio

EBS0.95x

SRZN7.31x

P/FCF Ratio

EBS10.26x

SRZNN/A

EV/FCF

EBS22.72x

SRZN-6.94x

PEG Ratio

EBSN/A

SRZNN/A

Forward P/E (NTM)

EBSN/A

SRZNN/A

Forward P/S (NTM)

EBSN/A

SRZN118.58x

Revenue (TTM)

EBS$770M

SRZN$12M

Revenue Growth (YoY)

EBS-9.6%

SRZN-8.8%

Forward Rev Growth

EBS7.1%

SRZN-82.6%

Gross Margin (TTM)

EBS55.8%

SRZN0.0%

Operating Margin (TTM)

EBS0.0%

SRZN0.0%

EBITDA Margin (TTM)

EBS28.7%

SRZN-383.4%

Net Margin (TTM)

EBS-23.0%

SRZN-2885.3%

FCF Margin (TTM)

EBS4.6%

SRZN-303.9%

Net Income (TTM)

EBS$-177M

SRZN$-332M

FCF (TTM)

EBS$36M

SRZN$-35M

EPS (TTM)

EBS-$3.43

SRZN-$28.48

ROE (TTM)

EBS-3591.0%

SRZN58.2%

ROA (TTM)

EBS-1356.0%

SRZN-30962.0%

ROIC (TTM)

EBS-1622.0%

SRZN58.2%

Cash

EBS$140M

SRZN$102M

Debt

EBS$582M

SRZN$0

Net Cash/Debt

EBS$-442M

SRZN$102M

Current Ratio (TTM)

EBS5.42x

SRZN12.14x

Quick Ratio (TTM)

EBS2.74x

SRZN11.88x

Debt/Equity (TTM)

EBS1.70x

SRZN0.00x

Debt/Assets (TTM)

EBS0.0%

SRZN0.0%

Interest Coverage (TTM)

EBSN/A

SRZNN/A

Net Debt/EBITDA (TTM)

EBS0.00x

SRZN0.00x

Beta

EBS2.42

SRZN0.53

52W Performance

EBS-28.6%

SRZN111.5%

YTD Performance

EBS-43.6%

SRZN37.8%

% from 52W High

EBS-49.8%

SRZN-21.5%

% from 52W Low

EBS61.9%

SRZN160.7%

Asset Turnover (TTM)

EBS0.59x

SRZN0.11x

FCF Yield (TTM)

EBS9.7%

SRZN-10.1%

Earnings Yield (TTM)

EBS-48.5%

SRZN-96.4%

Dividend Yield (TTM)

EBSN/A

SRZNN/A

Rule of 40

EBS-4.9

SRZN-312.7

EV/GP/RG

EBS0.27

SRZNN/A

Ticker research

View EBS research View SRZN research

Metric	EBS Emergent BioSolutions Inc	SRZN Surrozen Inc
Market & Valuation
Market Cap	$364M	$345M
Enterprise Value	$806M	$243M
Price	$7.06	$29.69
P/E Ratio	N/A	N/A
P/S Ratio	0.47x	29.95x
EV/Sales	1.05x	21.08x
EV/EBITDA	3.65x	0.00x
P/B Ratio	0.95x	7.31x
P/FCF Ratio	10.26x	N/A
EV/FCF	22.72x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	118.58x
Revenue & Growth
Revenue (TTM)	$770M	$12M
Revenue Growth (YoY)	-9.6%	-8.8%
Forward Rev Growth	7.1%	-82.6%
Profitability
Gross Margin (TTM)	55.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	28.7%	-383.4%
Net Margin (TTM)	-23.0%	-2885.3%
FCF Margin (TTM)	4.6%	-303.9%
Net Income (TTM)	$-177M	$-332M
FCF (TTM)	$36M	$-35M
EPS (TTM)	-$3.43	-$28.48
ROE (TTM)	-3591.0%	58.2%
ROA (TTM)	-1356.0%	-30962.0%
ROIC (TTM)	-1622.0%	58.2%
Financial Health
Cash	$140M	$102M
Debt	$582M	$0
Net Cash/Debt	$-442M	$102M
Current Ratio (TTM)	5.42x	12.14x
Quick Ratio (TTM)	2.74x	11.88x
Debt/Equity (TTM)	1.70x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	0.53
52W Performance	-28.6%	111.5%
YTD Performance	-43.6%	37.8%
% from 52W High	-49.8%	-21.5%
% from 52W Low	61.9%	160.7%
Efficiency & Yields
Asset Turnover (TTM)	0.59x	0.11x
FCF Yield (TTM)	9.7%	-10.1%
Earnings Yield (TTM)	-48.5%	-96.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4.9	-312.7
EV/GP/RG	0.27	N/A
Ticker research	View EBS research	View SRZN research

Valuation

P/S Ratio

EBS

0.47x

SRZN

29.95x

EV/FCF

SRZN

-6.94x

EBS

22.72x

Growth & revenue

Revenue Growth TTM

SRZN

-8.8%

EBS

-9.6%

Forward Revenue Growth

EBS

7.1%

SRZN

-82.6%

Profitability & performance

Gross Margin

EBS

55.8%

SRZN

0.0%

ROE

SRZN

58.2%

EBS

-3591.0%

FCF Yield %

EBS

9.7%

SRZN

-10.1%

52-Week Performance

SRZN

111.5%

EBS

-28.6%

Detailed metrics comparison

EBS

Emergent BioSolutions Inc

SRZN

Surrozen Inc

Market Cap

EBS$364M

SRZN$345M

Enterprise Value

EBS$806M

SRZN$243M

Price

EBS$7.06

SRZN$29.69

P/E Ratio

EBSN/A

SRZNN/A

P/S Ratio

EBS0.47x

SRZN29.95x

EV/Sales

EBS1.05x

SRZN21.08x

EV/EBITDA

EBS3.65x

SRZN0.00x

P/B Ratio

EBS0.95x

SRZN7.31x

P/FCF Ratio

EBS10.26x

SRZNN/A

EV/FCF

EBS22.72x

SRZN-6.94x

PEG Ratio

EBSN/A

SRZNN/A

Forward P/E (NTM)

EBSN/A

SRZNN/A

Forward P/S (NTM)

EBSN/A

SRZN118.58x

Revenue (TTM)

EBS$770M

SRZN$12M

Revenue Growth (YoY)

EBS-9.6%

SRZN-8.8%

Forward Rev Growth

EBS7.1%

SRZN-82.6%

Gross Margin (TTM)

EBS55.8%

SRZN0.0%

Operating Margin (TTM)

EBS0.0%

SRZN0.0%

EBITDA Margin (TTM)

EBS28.7%

SRZN-383.4%

Net Margin (TTM)

EBS-23.0%

SRZN-2885.3%

FCF Margin (TTM)

EBS4.6%

SRZN-303.9%

Net Income (TTM)

EBS$-177M

SRZN$-332M

FCF (TTM)

EBS$36M

SRZN$-35M

EPS (TTM)

EBS-$3.43

SRZN-$28.48

ROE (TTM)

EBS-3591.0%

SRZN58.2%

ROA (TTM)

EBS-1356.0%

SRZN-30962.0%

ROIC (TTM)

EBS-1622.0%

SRZN58.2%

Cash

EBS$140M

SRZN$102M

Debt

EBS$582M

SRZN$0

Net Cash/Debt

EBS$-442M

SRZN$102M

Current Ratio (TTM)

EBS5.42x

SRZN12.14x

Quick Ratio (TTM)

EBS2.74x

SRZN11.88x

Debt/Equity (TTM)

EBS1.70x

SRZN0.00x

Debt/Assets (TTM)

EBS0.0%

SRZN0.0%

Interest Coverage (TTM)

EBSN/A

SRZNN/A

Net Debt/EBITDA (TTM)

EBS0.00x

SRZN0.00x

Beta

EBS2.42

SRZN0.53

52W Performance

EBS-28.6%

SRZN111.5%

YTD Performance

EBS-43.6%

SRZN37.8%

% from 52W High

EBS-49.8%

SRZN-21.5%

% from 52W Low

EBS61.9%

SRZN160.7%

Asset Turnover (TTM)

EBS0.59x

SRZN0.11x

FCF Yield (TTM)

EBS9.7%

SRZN-10.1%

Earnings Yield (TTM)

EBS-48.5%

SRZN-96.4%

Dividend Yield (TTM)

EBSN/A

SRZNN/A

Rule of 40

EBS-4.9

SRZN-312.7

EV/GP/RG

EBS0.27

SRZNN/A

Ticker research

View EBS research View SRZN research

Metric	EBS Emergent BioSolutions Inc	SRZN Surrozen Inc
Market & Valuation
Market Cap	$364M	$345M
Enterprise Value	$806M	$243M
Price	$7.06	$29.69
P/E Ratio	N/A	N/A
P/S Ratio	0.47x	29.95x
EV/Sales	1.05x	21.08x
EV/EBITDA	3.65x	0.00x
P/B Ratio	0.95x	7.31x
P/FCF Ratio	10.26x	N/A
EV/FCF	22.72x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	118.58x
Revenue & Growth
Revenue (TTM)	$770M	$12M
Revenue Growth (YoY)	-9.6%	-8.8%
Forward Rev Growth	7.1%	-82.6%
Profitability
Gross Margin (TTM)	55.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	28.7%	-383.4%
Net Margin (TTM)	-23.0%	-2885.3%
FCF Margin (TTM)	4.6%	-303.9%
Net Income (TTM)	$-177M	$-332M
FCF (TTM)	$36M	$-35M
EPS (TTM)	-$3.43	-$28.48
ROE (TTM)	-3591.0%	58.2%
ROA (TTM)	-1356.0%	-30962.0%
ROIC (TTM)	-1622.0%	58.2%
Financial Health
Cash	$140M	$102M
Debt	$582M	$0
Net Cash/Debt	$-442M	$102M
Current Ratio (TTM)	5.42x	12.14x
Quick Ratio (TTM)	2.74x	11.88x
Debt/Equity (TTM)	1.70x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	0.53
52W Performance	-28.6%	111.5%
YTD Performance	-43.6%	37.8%
% from 52W High	-49.8%	-21.5%
% from 52W Low	61.9%	160.7%
Efficiency & Yields
Asset Turnover (TTM)	0.59x	0.11x
FCF Yield (TTM)	9.7%	-10.1%
Earnings Yield (TTM)	-48.5%	-96.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4.9	-312.7
EV/GP/RG	0.27	N/A
Ticker research	View EBS research	View SRZN research